VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
73 hedge funds and large institutions have $175M invested in Viracta Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
4% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 24
Holders
73
Holding in Top 10
–
Calls
$2.28M
Puts
$562K
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.67M | |
| 3 | +$1.59M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.26M |
| 5 |
CI
Cowen Inc
New York
|
+$1.15M |
Top Sellers
| 1 | -$3.9M | |
| 2 | -$1.03M | |
| 3 | -$798K | |
| 4 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
-$592K |
| 5 |
MOACM
Mutual of America Capital Management
New York
|
-$577K |